Objective: To investigate whether the fetal fibronectin assay would be useful for determining if a woman was close to a term delivery. If effective, this test would allow parturient women to stay in their communities longer.
Design: This feasibility study used a prospective cohort design to examine the negative predictive value of the fetal fibronectin test at term.
Setting: Iqaluit, NU.
Participants: A total of 30 parturient women from rural and isolated communities in Nunavut.
Intervention: Starting at 36 weeks' gestation, women were tested every 2 days, and after 39 weeks this increased to every day until labour.
Main Outcome Measures: The negative predictive value of the fetal fibronectin test was assessed.
Results: Women were no more likely to give birth at 7 or more days after their last negative fetal fibronectin test result relative to their likelihood of giving birth at 6 or fewer days after their last negative test result. Hence, the presence of fetal fibronectin in cervical secretion did not predict term delivery.
Conclusion: This project indicated that the fetal fibronectin test did not have adequate sensitivity or specificity as a diagnostic measure to predict a delay of labour at term.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851407 | PMC |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!